Corona Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
2,265.70
31.1 (1.39%)
BSENSE

Nov 20

BSE+NSE Vol: 1.84 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
441.17
422.43
353.09
342.42
361.13
346.54
293.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
441.17
422.43
353.09
342.42
361.13
346.54
293.69
Raw Material Cost
35.01
32.65
27.73
24.82
25.90
25.07
25.89
Purchase of Finished goods
68.24
57.20
46.34
41.15
28.11
34.77
45.78
(Increase) / Decrease In Stocks
-22.74
-12.33
-7.83
-5.70
14.64
5.94
-14.81
Employee Cost
124.24
122.09
106.63
95.94
103.00
97.44
84.85
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
140.47
129.69
118.20
103.05
111.01
113.54
97.76
Total Expenditure (Excl Depreciation)
345.22
329.30
291.07
259.26
282.66
276.76
239.47
Operating Profit (PBDIT) excl Other Income
95.95
93.13
62.02
83.16
78.47
69.78
54.22
Other Income
2.48
3.15
4.11
2.24
2.27
2.02
1.42
Operating Profit (PBDIT)
98.43
96.28
66.13
85.40
80.74
71.80
55.64
Interest
2.75
2.69
1.38
1.66
1.93
1.99
2.20
Exceptional Items
0.00
0.00
0.00
-19.10
0.00
0.00
0.00
Gross Profit (PBDT)
95.68
93.59
64.75
64.64
78.81
69.81
53.44
Depreciation
15.06
13.24
10.29
9.45
9.20
8.92
10.04
Profit Before Tax
80.75
80.36
54.74
55.21
69.78
60.69
43.61
Tax
20.44
20.25
9.41
13.94
17.46
14.49
12.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
60.18
60.10
45.05
41.25
52.15
46.40
31.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
60.18
60.10
45.05
41.25
52.15
46.40
31.34
Share in Profit of Associates
0.13
0.01
0.28
0.02
0.17
-0.20
0.21
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
60.31
60.11
45.33
41.27
52.32
46.20
31.55
Equity Capital
61.16
61.16
61.16
61.16
61.16
61.16
61.16
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
9.86
9.83
7.41
6.75
8.55
7.55
5.16
Diluted Earnings per share
9.86
9.83
7.41
6.75
8.55
7.55
5.16
Operating Profit Margin (Excl OI)
21.75%
22.05%
17.56%
24.29%
21.73%
20.14%
18.46%
Gross Profit Margin
21.69%
22.16%
18.34%
18.88%
21.82%
20.14%
18.2%
PAT Margin
13.67%
14.23%
12.84%
12.05%
14.49%
13.33%
10.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 4.44% vs 19.64% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 0.33% vs 32.61% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 3.03% vs 50.16% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 2.23% vs 94.93% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Corona Remedies With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
441.17
2,370.00
-1,928.83
-81.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
441.17
2,370.00
-1,928.83
-81.39%
Raw Material Cost
35.01
652.40
-617.39
-94.63%
Purchase of Finished goods
68.24
86.10
-17.86
-20.74%
(Increase) / Decrease In Stocks
-22.74
21.60
-44.34
-205.28%
Employee Cost
124.24
829.80
-705.56
-85.03%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
140.47
539.60
-399.13
-73.97%
Total Expenditure (Excl Depreciation)
345.22
2,129.50
-1,784.28
-83.79%
Operating Profit (PBDIT) excl Other Income
95.95
240.50
-144.55
-60.10%
Other Income
2.48
14.40
-11.92
-82.78%
Operating Profit (PBDIT)
98.43
254.90
-156.47
-61.38%
Interest
2.75
58.40
-55.65
-95.29%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
95.68
196.50
-100.82
-51.31%
Depreciation
15.06
134.80
-119.74
-88.83%
Profit Before Tax
80.75
61.70
19.05
30.88%
Tax
20.44
30.70
-10.26
-33.42%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
60.18
31.00
29.18
94.13%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
60.18
31.00
29.18
94.13%
Share in Profit of Associates
0.13
0.00
0.13
Minority Interest
0.00
-0.20
0.20
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
60.31
31.20
29.11
93.30%
Equity Capital
61.16
15.80
45.36
287.09%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
9.86
1.97
7.89
400.51%
Diluted Earnings per share
9.86
1.97
7.89
400.51%
Operating Profit Margin (Excl OI)
21.75%
10.19%
0.00
11.56%
Gross Profit Margin
21.69%
8.33%
0.00
13.36%
PAT Margin
13.67%
1.31%
0.00
12.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 441.17 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 4.44% vs 19.64% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 22.16% vs 15.06% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 60.31 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 0.33% vs 32.61% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 15.27% vs 21.76% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 95.95 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 3.03% vs 50.16% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 22.28% vs 17.43% in Sep 2025

Quarterly - Interest
Interest 2.75 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 2.23% vs 94.93% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 42.49% vs -32.75% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.75%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025